Phase II study of cabazitaxel as second-line therapy in stage IV non-small cell lung cancer (NSCLC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e19107-e19107
Author(s):  
Devika Das ◽  
Francisco Robert ◽  
Rodolfo Bordoni ◽  
Stefan C. Grant ◽  
Mansoor N. Saleh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Stage Iv ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer

Lung Cancer ◽  
2009 ◽  
Vol 64 (1) ◽  
pp. 60-65 ◽  
Author(s):  
Tim Eisen ◽  
Nick Thatcher ◽  
Serge Leyvraz ◽  
Wilson H. Miller ◽  
Felix Couture ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

A phase II study of KOS-862 (epothilone D) as second-line therapy in non-small cell lung cancer

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7127-7127 ◽  
Author(s):  
L. Yee ◽  
T. Lynch ◽  
M. Villalona-Calero ◽  
N. Rizvi ◽  
N. Gabrail ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Epothilone D

A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer

Lung Cancer ◽  
2007 ◽  
Vol 57 (1) ◽  
pp. 84-88 ◽  
Author(s):  
Chirag Shah ◽  
Neal Ready ◽  
Michel Perry ◽  
Jeffrey Kirshner ◽  
Ajeet Gajra ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

Scheduled administration of low dose irinotecan before gemcitabine in the second line therapy of non-small cell lung cancer: a phase II study

2008 ◽  
Vol 19 (7) ◽  
pp. 749-752 ◽  
Author(s):  
Nithya Ramnath ◽  
Jihnhee Yu ◽  
Nikhil I. Khushalani ◽  
Ronald H. Gottlieb ◽  
James K. Schwarz ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Low Dose ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer

Lung Cancer ◽  
2004 ◽  
Vol 44 (2) ◽  
pp. 231-239 ◽  
Author(s):  
Giovanni Luca Ceresoli ◽  
Vanesa Gregorc ◽  
Stefano Cordio ◽  
Katia Bruna Bencardino ◽  
Stefano Schipani ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document